Literature DB >> 10489088

Reduction of tremor severity and disability following behavioral relaxation training.

D A Lundervold1, M F Belwood, J L Craney, R Poppen.   

Abstract

The effects of behavioral relaxation training (BRT) for the treatment of moderate to severe essential tremor (ET) was evaluated with two older adults, ages 73 and 83, using a single-case design and statistical analysis. Measures included within-session clinician and self-rated tremor severity and disability in activities of daily living (ADL), EMG activity, and daily self-ratings of tremor severity and ADL disabilities. Following a brief 2-4 week baseline period BRT was conducted. Clinically significant reductions of 47-66% in within session clinical and self-rated tremor severity and daily self-ratings were obtained. Statistically significant changes in self- and clinician ratings occurred following BRT. In some cases, EMG activity also declined following intervention. Results at a seven week follow up were mixed and related to continued use of relaxation skills. While the cost ratio (medication: BRT) indicates that relaxation training is more expensive relative to standard medical intervention, cost-benefit to patients off sets the financial difference. Relaxation training may be an efficacious first step in a biobehavioral stepped care treatment model.

Entities:  

Mesh:

Year:  1999        PMID: 10489088     DOI: 10.1016/s0005-7916(99)00015-4

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  2 in total

Review 1.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Social anxiety, tremor severity, and tremor disability: a search for clinically relevant measures.

Authors:  Duane A Lundervold; Patrick A Ament; Peter Holt
Journal:  Psychiatry J       Date:  2013-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.